LII
Lennox International Inc.
LII has lower modeled downside risk, despite its lower overall score.
RKLB
Rocket Lab USA, Inc.
RKLB has the edge over LII overall, supported by stronger modeled upside and stronger fundamentals.
LII Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Healthy |
LII's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
LII PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 16x | $348 | — |
| Forward | 16x | $348 | — |
| Cheap | 19x | $412 | +18% |
| Fair | 24x | $526 | +51% |
| Expensive | 30x | $651 | +87% |
Historical ranges are pointers, not guarantees.
LII's PE is in its cheap range at 16.1x. On analysts' estimates for next year's earnings, today's price would be 15.6x.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
LII Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Weakening | |
| Limited | |
| Low |
Analysts expect LII's profitability to weaken, with its earnings and revenue holding steady. However, they disagree widely on these estimates.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
RKLB has the edge over LII on the outlook, with more favorable earnings and revenue expectations.
LII Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.37 | +3.8% |
| Q3 2026 | $21.55 | -9% |
| Q2 2026 | $22.12 | -5.4% |
| Q1 2026 | $22.22 | -1% |
| Q4 2025 | $22.24 | -1.3% |
| Q3 2025 | $23.69 | +12% |
| Q2 2025 | $23.39 | +30% |
| Q1 2025 | $22.44 | +30% |
| Q4 2024 | $22.54 | +36% |
LII has the edge over RKLB on earnings quality, reporting a profit while its opponent remains loss making.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
LII Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.6B | +10% |
| Q2 2026 | $1.5B | +3% |
| Q1 2026 | $1.1B | +5.8% |
| Q4 2025 | $1.2B | -11% |
| Q3 2025 | $1.4B | -4.8% |
| Q2 2025 | $1.5B | +3.4% |
| Q1 2025 | $1.1B | +2.4% |
| Q4 2024 | $1.3B | +16% |
LII's revenue grew through 2024 and has held roughly level since: $1.6B last quarter, up 10% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | -1.9 points |
| Q2 2026 | 23% | -0.6 points |
| Q1 2026 | 14% | -0.1 points |
| Q4 2025 | 16% | -1.8 points |
| Q3 2025 | 22% | +1.5 points |
| Q2 2025 | 24% | +1.5 points |
| Q1 2025 | 15% | -1.4 points |
| Q4 2024 | 18% | +2.1 points |
LII has the edge over RKLB on profitability, with a higher operating margin.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over LII on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
LII Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $362.1M | +37% |
| Q2 2026 | $136.3M | +134% |
| Q1 2026 | -$39.4M | +$21.9M |
| Q4 2025 | $376.7M | +38% |
| Q3 2025 | $265.1M | -35% |
| Q2 2025 | $58.3M | -61% |
| Q1 2025 | -$61.3M | -$9M |
| Q4 2024 | $272.2M | +50% |
LII has the edge over RKLB on cash generation, producing positive trailing cash flow while its opponent burns cash.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
LII Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.4x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.3x | Healthy |
| Q4 2025 | 1.2x | Healthy |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 1.0x | Very low |
| Q1 2025 | 0.8x | Very low |
| Q4 2024 | 0.7x | Very low |
LII's net debt is about 1.4 years of its operating earnings (EBITDA), up from less than a year a year ago.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LII Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.8 | Neutral |
| Stochastic | 15.4 | Oversold |
LII's weekly RSI is 34 (neutral) and its Stochastic is 15 (oversold).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
LII PE vs Industrials Sector
| Metric | LII | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 24x | 33% below |
| PE % | 2 | 58 | 56 pts below |
LII is trading at 16x earnings, a 33% discount to the Industrials sector's median of 24x.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
LII Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $356.8 | 2.4% below |
| 20 week MA | $412.6 | 16% below |
| 50 week MA | $470.9 | 26% below |
| 100 week MA | $520.2 | 33% below |
| 200 week MA | $475.9 | 27% below |
LII is in a downtrend: it's below all five of its weekly moving averages, and 27% below its 200-week average.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB has the edge over LII on trend strength, trading above more of its moving averages.
LII Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $243.3 | $273.4 | +12% |
| 2021 | $273.4 | $316.1 | +16% |
| 2022 | $316.1 | $243.1 | -23% |
| 2023 | $243.1 | $447.5 | +84% |
| 2024 | $447.5 | $620.0 | +39% |
| 2025 | $620.0 | $498.2 | -20% |
| 2026 YTD | $498.2 | $348.1 | -30% |
LII is down 30% so far in 2026, after finishing higher in four of the previous six years.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB has the edge over LII on returns for 2026, with the stronger performance.